ANIP
ANIP
NASDAQ · Pharmaceuticals

Ani Pharmaceuticals Inc

$78.25
-4.38 (-5.30%)
As of Aug 8, 10:05 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target -53.1% upside
Low Target $28.36
Average Target $36.71
High Target $54.52
Current Price $78.25
Current
$78.25
Target
$36.71
$28.36 $36.71 avg $54.52
Scenario Analysis
Bear Case
$28.36
-63.8%
Low target
Base Case
$36.71
-53.1%
Avg target
Bull Case
$54.52
+-30.3%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$99.50
-21.4% from high
52-Week Low
$64.99
+20.4% from low
Target vs 52W High
$36.71
-63.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%